Retrospective Analysis of 12 Months Glaucoma Implant Efficacy: XEN45 and PreserFlo Microshunt.

Giulia SalettaAntonios AlexoudisZisis GatzioufasMatthias GrieshaberAnthia PapazoglouMarkus TschoppMarc TötebergKonstantin Gugleta

Published in: Klinische Monatsblatter fur Augenheilkunde (2022)

Both methods demonstrate satisfactory IOP control within a 12-month postoperative period with practically no serious adverse events/complications, but with relatively high numbers of subsequent interventions (needlings), particularly in the XEN45 group.

Keyphrases

patients undergoing
physical activity
risk factors
soft tissue
optic nerve